Add new attachment

Only authorized users are allowed to upload new attachments.

List of attachments

Kind Attachment Name Size Version Date Modified Author Change note
xlsx
All_methods_gene_summary.xlsx 4,539.9 kB 1 22-Jul-2016 12:12 LingyunWu
zip
BiNGO results.zip 167.4 kB 1 22-Jul-2016 12:14 LingyunWu
xlsx
Enrichment_pathway_description... 12.8 kB 1 22-Jul-2016 12:13 LingyunWu
zip
MarkRank code and data.zip 273,914.8 kB 1 22-Jul-2016 23:47 LingyunWu MD5: 91BFE251E6C2B04357FF83581EFE09D2
xlsx
MarkRank_gene_summary.xlsx 3,274.7 kB 1 22-Jul-2016 12:13 LingyunWu
pdf
Supplementary_Materials.pdf 2,474.0 kB 1 16-Jan-2017 23:14 LingyunWu

This page (revision-6) was last changed on 28-Feb-2018 12:24 by LingyunWu

This page was created on 22-Jul-2016 11:05 by unknown

Only authorized users are allowed to rename pages.

Only authorized users are allowed to delete pages.

Difference between version and

At line 1 changed 2 lines
__MarkRank__: Prioritization of network biomarkers for complex diseases
* Last updated: July 22, 2016
__MarkRank__: Discovering cooperative biomarkers for heterogeneous complex disease diagnoses
* Last updated: January 16, 2017
At line 6 changed one line
Biomarkers with high reproducibility and accurate prediction performance can contribute to comprehending the underlying pathogenesis of related complex diseases, which can further facilitate disease diagnosis and therapy. With the powerful technologies stemming from systems biology, the types of disease-related biomarkers have been gradually refocused from conventional individual genes to current network-based disease biomarker modules. Techniques integrating both expression profiles and biological networks for the identification of connected disease biomarkers are receiving increasing interest. However, the incompleteness of protein-protein interaction (PPI) networks and the intrinsic heterogeneity of complex diseases may hinder the efficacy of connected biomarker identification. In this paper, we propose a novel method, MarkRank, to prioritize disease genes by integrating multi-source information including human PPI network, prior information about related diseases, and the discriminative power of cooperative gene combinations. In comparison with well-designed simulation studies and real biological datasets, MarkRank, explicitly taking the heterogeneity of diseases into consideration, achieves a superior performance than existing methods, exhibits high specificity associated with the related diseases, and can help exploring the underlying pathogenesis of complex disease in a new perspective. MarkRank has been implemented in the R package Corbi, which can be readily installed and used in R.
Biomarkers with high reproducibility and accurate prediction performance can contribute to comprehending the underlying pathogenesis of related complex diseases and further facilitate disease diagnosis and therapy. Techniques integrating gene expression profiles and biological networks for the identification of network-based disease biomarkers are receiving increasing interest. In this study, we proposed a novel method, MarkRank, to discover cooperative biomarkers for heterogeneous diseases by integrating multi-source information, including biological networks, prior information about related diseases, and the cooperative effects of gene combinations. By innovatively constructing a gene cooperation network to capture the cooperative effects of gene combinations and explicitly taking the heterogeneity of complex diseases into consideration, MarkRank achieves superior performance compared to existing methods in both simulation studies and real datasets. The biomarkers identified by MarkRank not only have a better prediction accuracy in the Monte Carlo cross-validation procedure but also have stronger topological relationships in the biological network and exhibit high specificity associated with the related diseases. Furthermore, the top genes identified by MarkRank involve crucial biological processes of related diseases and give a good prioritization for known disease genes. In conclusion, the MarkRank method is an efficient and effective computational tool for discovering disease biomarkers and can help in the exploration of the underlying pathogenesis of complex diseases. MarkRank has been implemented in the R package Corbi, which is publicly available at the CRAN website (http://cran.r-project.org/web/packages/Corbi/). The open source codes, original datasets and additional materials are available at http://doc.aporc.org/wiki/MarkRank.
At line 10 changed one line
* Duanchen Sun, Xianwen Ren, Eszter Ari, Tamas Korcsmaros, Peter Csermely, Ling-Yun Wu. Prioritization of network biomarkers for complex diseases via MarkRank. In submission, 2016.
* Duanchen Sun, Xianwen Ren, Eszter Ari, Tamas Korcsmaros, Peter Csermely, Ling-Yun Wu. Discovering cooperative biomarkers for heterogeneous complex disease diagnoses. Briefings in Bioinformatics, bbx090, 2017.
At line 19 added 11 lines
!!!Additional Materials
* [Supplementary_Materials.pdf]
* [Enrichment_pathway_description.xlsx]
* [MarkRank_gene_summary.xlsx]
* [All_methods_gene_summary.xlsx]
* [BiNGO results.zip]
* [MarkRank code and data.zip]
Version Date Modified Size Author Changes ... Change note
6 28-Feb-2018 12:24 2.702 kB LingyunWu to previous
5 16-Jan-2017 23:15 2.68 kB LingyunWu to previous | to last
4 16-Jan-2017 23:13 2.68 kB LingyunWu to previous | to last
3 08-Aug-2016 00:17 2.292 kB LingyunWu to previous | to last
2 22-Jul-2016 23:57 2.261 kB LingyunWu to previous | to last
1 22-Jul-2016 11:05 2.065 kB unknown to last
« This page (revision-6) was last changed on 28-Feb-2018 12:24 by LingyunWu